Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,247 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $820.69 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $294.04 | 11 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $241.03 | 6 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $209.22 | 2 | $0 (2021) |
| ABBVIE INC. | $175.87 | 6 | $0 (2024) |
| NEW WORLD MEDICAL,INC. | $117.43 | 1 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $91.97 | 4 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $79.18 | 2 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $38.54 | 2 | $0 (2018) |
| Harrow Eye, LLC | $35.36 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.62 | 6 | ABBVIE INC. ($65.05) |
| 2023 | $254.52 | 9 | AbbVie Inc. ($92.63) |
| 2022 | $219.15 | 5 | NEW WORLD MEDICAL,INC. ($117.43) |
| 2021 | $385.21 | 9 | Allergan, Inc. ($149.76) |
| 2020 | $33.91 | 2 | Novartis Pharmaceuticals Corporation ($17.02) |
| 2019 | $651.05 | 15 | Allergan Inc. ($352.69) |
| 2018 | $161.83 | 8 | Novartis Pharmaceuticals Corporation ($110.18) |
| 2017 | $372.46 | 4 | Allergan Inc. ($288.24) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| 06/05/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.34 | General |
| 06/04/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX GEL (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/09/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $60.80 | General |
| 11/11/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $63.95 | General |
| Category: RETINA | ||||||
| 11/07/2017 | Regeneron Pharmaceuticals, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $84.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/30/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $120.03 | General |
| Category: RETINA | ||||||
| 05/18/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $104.26 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,638 | 6,437 | $2.3M | $602,557 |
| 2022 | 16 | 2,909 | 6,376 | $2.4M | $625,587 |
| 2021 | 15 | 2,527 | 5,610 | $2.1M | $568,726 |
| 2020 | 16 | 3,126 | 6,096 | $2.2M | $646,148 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 90 | 102 | $21,410 | $9,152 | 42.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 65 | 65 | $24,416 | $5,848 | 23.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 184 | 271 | $39,075 | $4,741 | 12.1% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 17 | 20 | $25,356 | $3,455 | 13.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 155 | 222 | $32,075 | $2,381 | 7.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 21 | 26 | $4,825 | $843.39 | 17.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 13 | 14 | $2,185 | $580.29 | 26.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 44 | 376 | $870,650 | $274,761 | 31.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 563 | 1,306 | $386,254 | $113,378 | 29.4% |
| 67028 | Injection of drug into eye | Office | 2021 | 168 | 564 | $155,700 | $49,823 | 32.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 613 | 1,410 | $146,970 | $41,680 | 28.4% |
| 92250 | Photography of the retina | Office | 2021 | 414 | 886 | $117,423 | $25,645 | 21.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 116 | 349 | $201,670 | $19,518 | 9.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 96 | 96 | $36,384 | $9,872 | 27.1% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2021 | 105 | 112 | $24,735 | $9,594 | 38.8% |
| 67145 | Preventive retinal detachment treatment by heat or laser, 1 or more sessions | Office | 2021 | 19 | 21 | $25,214 | $8,127 | 32.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $25,680 | $7,910 | 30.8% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 163 | 224 | $31,160 | $4,066 | 13.0% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 112 | 143 | $20,390 | $1,636 | 8.0% |
| 76512 | Ultrasound of eye disease, growth, or structure | Office | 2021 | 22 | 31 | $5,702 | $1,129 | 19.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 18 | 18 | $2,825 | $897.16 | 31.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 11 | 11 | $2,295 | $688.61 | 30.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 80 | 400 | $910,350 | $293,628 | 32.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 715 | 1,362 | $392,337 | $119,907 | 30.6% |
| 67028 | Injection of drug into eye | Office | 2020 | 257 | 635 | $165,900 | $52,076 | 31.4% |
About Dr. Stanislav Zhuk, M.D
Dr. Stanislav Zhuk, M.D is a Ophthalmology healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922201870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanislav Zhuk, M.D has received a total of $2,247 in payments from pharmaceutical and medical device companies, with $168.62 received in 2024. These payments were reported across 58 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,247).
As a Medicare-enrolled provider, Zhuk has provided services to 11,200 Medicare beneficiaries, totaling 24,519 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Metairie, LA
- Active Since 06/07/2007
- Last Updated 10/08/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1922201870
Products in Payments
- OZURDEX (Drug) $892.30
- EYLEA (Biological) $344.41
- Kahook Dual Blade (Device) $117.43
- XIPERE (Drug) $91.97
- EYLEA AFLIBERCEPT INJECTION (Biological) $84.22
- BEOVU (Drug) $58.87
- LOTEMAX GEL (Drug) $38.54
- YUTIQ (Drug) $35.62
- IHEEZO (Drug) $35.36
- Syfovre (Drug) $31.11
- ACTHAR (Biological) $29.91
- EYLEA HD (Biological) $21.62
- Vabysmo (Drug) $20.24
- Iluvien (Drug) $17.51
- TEPEZZA (Drug) $16.71
- DUREZOL (Drug) $14.38
- BROLUCIZUMAB (Drug) $9.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Metairie
Dr. Ethan Stern, Md, MD
Ophthalmology — Payments: $14,351
John Frisbee, Md, MD
Ophthalmology — Payments: $12,347
Gwen Cousins, Md, MD
Ophthalmology — Payments: $10,416
Benjamin Guidry, Md, MD
Ophthalmology — Payments: $9,044
Dr. Henry Haley, M.d, M.D
Ophthalmology — Payments: $8,019
Scott Lanoux, Md, MD
Ophthalmology — Payments: $7,607